Provention Bio shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Provention Bio shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Provention Bio
Tip: Access up to 7 years of quarterly data
All positions including Provention Bio held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Provention Bio by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-06-30 | $2.8M | 116k | 24.10 |
| 2023-03-31 | $2.8M | 116k | 24.10 |
| 2022-12-31 | $719k | 68k | 10.57 |
| 2022-09-30 | $134k | 30k | 4.50 |
| 2022-06-30 | $207k | 52k | 4.00 |
| 2022-03-31 | $378k | 52k | 7.32 |
| 2021-12-31 | $285k | 51k | 5.62 |
| 2021-09-30 | $257k | 40k | 6.40 |
| 2021-06-30 | $335k | 40k | 8.43 |
| 2021-03-31 | $287k | 27k | 10.50 |
| 2020-12-31 | $463k | 27k | 16.94 |
| 2020-09-30 | $350k | 27k | 12.83 |
| 2020-06-30 | $385k | 27k | 14.11 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas